Inclusion criteria included CD4 count less than 100 cells/μl, microbiologically confirmed TB or clinical diagnosis with symptomatic response to antituberculosis treatment, and starting ART within 30 days after starting antituberculosis treatment [12▪▪]. This evidence concerns the gene CD4 and tuberculosis.